Cardiovascular Systems Inc. (CSII)

49.91
0.97 1.90
NASDAQ : Health Technology
Prev Close 50.88
Open 50.97
Day Low/High 49.89 / 51.30
52 Wk Low/High 24.84 / 52.54
Volume 165.50K
Avg Volume 302.80K
Exchange NASDAQ
Shares Outstanding 35.27M
Market Cap 1.82B
P/E Ratio N/A
Div & Yield N.A. (N.A)
Cardiovascular Systems Receives FDA Clearance For Low Profile, 60cm Diamondback Devices Designed To Expand The Treatment Of Peripheral Artery Disease (PAD)

Cardiovascular Systems Receives FDA Clearance For Low Profile, 60cm Diamondback Devices Designed To Expand The Treatment Of Peripheral Artery Disease (PAD)

Cardiovascular Systems, Inc. (NASDAQ: CSII) (CSI), announced today it has received FDA clearance of its new Diamondback 360 ® 60cm Peripheral Orbital Atherectomy Systems (OAS) for the treatment of peripheral...

Cardiovascular Systems Releases One-Year Orbit II Coronary Data At 2014 Cardiovascular Research Technologies Conference

Cardiovascular Systems Releases One-Year Orbit II Coronary Data At 2014 Cardiovascular Research Technologies Conference

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), released one-year data from its ORBIT II study of the company’s Diamondback 360 ® Coronary Orbital Atherectomy System in treating severely calcified lesions...

Cardiovascular Systems To Present ORBIT II Coronary Data At 2014 Cardiovascular Research Technologies Conference

Cardiovascular Systems To Present ORBIT II Coronary Data At 2014 Cardiovascular Research Technologies Conference

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), will release one-year data from the ORBIT II study of the company’s Diamondback 360 ® Coronary Orbital Atherectomy System in treating severely calcified ...

Use Options For a Chance To Buy CSII at a 32% Discount

Use Options For a Chance To Buy CSII at a 32% Discount

Looking back to 75 days ago, Cardiovascular Systems priced a 2,608,696 share secondary stock offering at $30 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Monday, the stock is now 12.3% above the offering price.

Cardiovascular Systems Reports Fiscal 2014 Second-Quarter Financial Results

Cardiovascular Systems Reports Fiscal 2014 Second-Quarter Financial Results

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for vascular and coronary disease, today reported financial results...

Physician Demand Continues To Build For Cardiovascular Systems’ New Coronary Artery Disease Treatment Technology

Physician Demand Continues To Build For Cardiovascular Systems’ New Coronary Artery Disease Treatment Technology

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), today announced that physician demand continues to build throughout the United States for its recently approved Diamondback 360 ® Coronary Orbital Atherectomy...

Cardiovascular Systems To Webcast Fiscal 2014 Second-Quarter Earnings Conference Call Wednesday, January 29

Cardiovascular Systems To Webcast Fiscal 2014 Second-Quarter Earnings Conference Call Wednesday, January 29

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a live webcast of its fiscal 2014 second-quarter conference call on Wednesday, Jan.

Cardiovascular Systems Becomes Oversold (CSII)

Cardiovascular Systems Becomes Oversold (CSII)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Physicians Throughout U.S. Using Cardiovascular Systems’ New Technology To Treat Coronary Artery Disease

Physicians Throughout U.S. Using Cardiovascular Systems’ New Technology To Treat Coronary Artery Disease

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), today announced that its new Diamondback 360 ® Coronary Orbital Atherectomy System (OAS) is being used by physicians across the country to treat coronary artery...

Cardiovascular Systems Announces Closing Of Common Stock Offering And Full Exercise Of Underwriters’ Option To Purchase Additional Shares

Cardiovascular Systems Announces Closing Of Common Stock Offering And Full Exercise Of Underwriters’ Option To Purchase Additional Shares

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII) today announced the closing of its underwritten registered public offering of an aggregate of 3,000,000 shares of its common stock, including 391,304 shares of common...

Cardiovascular Systems Prices Public Offering Of Common Stock

Cardiovascular Systems Prices Public Offering Of Common Stock

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), a medical device company focused on developing and commercializing innovative interventional treatment systems for vascular disease, today announced the pricing of an...

Cardiovascular Systems Announces Proposed Public Offering Of Common Stock

Cardiovascular Systems Announces Proposed Public Offering Of Common Stock

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), a medical device company focused on developing and commercializing innovative interventional treatment systems for vascular disease, today announced that it intends to...

Cardiovascular Systems Reports Fiscal 2014 First-Quarter Financial Results

Cardiovascular Systems Reports Fiscal 2014 First-Quarter Financial Results

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today reported financial results for its...

6 Strong Small Cap Stocks For A Growing Economy

6 Strong Small Cap Stocks For A Growing Economy

James Dennin, Kapitall: This year small cap stocks - market cap between $300 million and $2 billion - grew twice [...]

Prominent Physicians To Present New Arterial Calcification Research At 2013 TCT Conference

Prominent Physicians To Present New Arterial Calcification Research At 2013 TCT Conference

Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII), announced today that new data about the treatment of arterial calcification will be unveiled at the 2013 Transcatheter Cardiovascular Therapeutics (TCT) conference in...

Cardiovascular Systems To Webcast Fiscal 2014 First-Quarter Earnings Conference Call Wednesday, October 30

Cardiovascular Systems To Webcast Fiscal 2014 First-Quarter Earnings Conference Call Wednesday, October 30

Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII) will host a live webcast of its fiscal 2014 first-quarter conference call on Wednesday, Oct.

Cardiovascular Systems Sponsoring Lunch Symposium On Arterial Calcium At 2013 VIVA Conference

Cardiovascular Systems Sponsoring Lunch Symposium On Arterial Calcium At 2013 VIVA Conference

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), is sponsoring a lunch symposium highlighting the challenges and treatment options for Peripheral Arterial Disease complicated by calcium at the 2013 Vascular ...

Cardiovascular Systems Reports Fiscal 2013 Fourth-Quarter And Full-Year Financial Results

Cardiovascular Systems Reports Fiscal 2013 Fourth-Quarter And Full-Year Financial Results

Cardiovascular Systems, Inc. (NASDAQ: CSII) Revenues of $28.

Cardiovascular Systems To Present PAD Data And Offer Educational Sessions At AMP Chicago 2013 Symposium

Cardiovascular Systems To Present PAD Data And Offer Educational Sessions At AMP Chicago 2013 Symposium

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, will present data from its studies of...

Cardiovascular Systems To Webcast Fiscal 2013 Fourth-Quarter Earnings Conference Call Wednesday, August 7

Cardiovascular Systems To Webcast Fiscal 2013 Fourth-Quarter Earnings Conference Call Wednesday, August 7

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a live webcast of its fiscal 2013 fourth-quarter conference call on Wednesday, Aug.

Oversold Conditions For Cardiovascular Systems (CSII)

Oversold Conditions For Cardiovascular Systems (CSII)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

4 Stocks Rising on Unusual Volume

4 Stocks Rising on Unusual Volume

Often when above-average volume moves into an equity, it precedes a large spike in volatility.

Cardiovascular Systems Prices Public Offering Of Common Stock

Cardiovascular Systems Prices Public Offering Of Common Stock

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), a medical device company focused on developing and commercializing innovative interventional treatment systems for vascular disease, today announced the pricing of an...

Cardiovascular Systems Announces Proposed Public Offering Of Common Stock

Cardiovascular Systems Announces Proposed Public Offering Of Common Stock

Cardiovascular Systems, Inc. (“CSI”) (Nasdaq: CSII), a medical device company focused on developing and commercializing innovative interventional treatment systems for vascular disease, today announced that...

Cardiovascular Systems Completes PMA Submission Of Orbital Atherectomy System For Coronary Artery Disease Treatment

Cardiovascular Systems Completes PMA Submission Of Orbital Atherectomy System For Coronary Artery Disease Treatment

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), announced today that it has submitted its Premarket Approval (PMA) application to the U.

Cardiovascular Systems’ Orbital Atherectomy Technology Highlighted At ACC Innovations Forum

Cardiovascular Systems’ Orbital Atherectomy Technology Highlighted At ACC Innovations Forum

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), was featured as part of the “Innovation and Technology Adoption” presentation during the Innovations Educational Forum at the 2013 American College of Cardiology...

Cardiovascular Systems Presents Results From Pivotal Coronary Trial At ACC

Cardiovascular Systems Presents Results From Pivotal Coronary Trial At ACC

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), presented pivotal 30-day data from its ORBIT II study of severely calcified coronary lesions at the 2013 American College of Cardiology (ACC) conference in San...

Cardiovascular Systems To Present Pivotal Orbit II Coronary Data At The 2013 American College Of Cardiology Conference

Cardiovascular Systems To Present Pivotal Orbit II Coronary Data At The 2013 American College Of Cardiology Conference

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), will present data from its ORBIT II study of coronary artery disease at the 2013 American College of Cardiology (ACC) conference in San Francisco, Mar.

TheStreet Quant Rating: C (Hold)